Background:Thepresenceofco-morbidities,includingunderlyingrespiratoryproblems,hasbeenidenti-fiedasariskfactorforsevereCOVID-19disease.InformationontheclinicalcourseofSARS-CoV-2infec-tioninchildrenwithcysticfibrosis(CF)islimited,yetvitaltoprovideaccurateadviceforchildrenwithCF,theirfamilies,caregiversandclinicalteams.Methods:CasesofSARS-CoV-2infectioninchildrenwithCFagedlessthan18yearswerecollatedbytheCFRegistryGlobalHarmonizationGroupacross13countriesbetween1Februaryand7August2020.Results:Dataon105childrenwerecollatedandanalysed.Medianageofcaseswastenyears(interquar-tilerange6–15),54%weremaleandmedianpercentagepredictedforcedexpiratoryvolumeinonesecond was94%(interquartilerange79–104).Themajority(71%)ofchildrenweremanagedinthecommunityduringtheirCOVID-19illness.Outof24childrenadmittedtohospital,sixrequiredsupplementaryoxygenandtwonon-invasiveventilation.Aroundhalfwereprescribedantibiotics,fivechildrenreceivedantivi-raltreatments,fourazithromycinandoneadditionalcorticosteroids.ChildrenthatwerehospitalisedhadlowerlungfunctionandreducedbodymassindexZ-scores.Onechilddiedsixweeksaftertestingposi-tiveforSARS-CoV-2followingadeteriorationthatwasnotattributedtoCOVID-19disease. Conclusions:SARS-CoV-2infectioninchildrenwithCFisusuallyassociatedwithamildillnessinthosewhodonothavepre-existingseverelungdisease

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study / R. Bain, R. Cosgriff, M. Zampoli, A. Elbert, P. Burgel, S.B. Carr, C. Castaños, C. Colombo, H. Corvol, A. Faro, C.H. Goss, H. Gutierrez, A. Jung, N. Kashirskaya, B.C. Marshall, J. Melo, P. Mondejar-Lopez, I. de Monestrol, L. Naehrlich, M.D. Pastor-Vivero, S. Rizvi, L.V.R.F.d.S. Filho, K.G. Brownlee, I.J. Haq, M. Brodlie. - In: JOURNAL OF CYSTIC FIBROSIS. - ISSN 1569-1993. - 20:1(2021), pp. 25-30. [10.1016/j.jcf.2020.11.021]

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

C. Colombo;
2021

Abstract

Background:Thepresenceofco-morbidities,includingunderlyingrespiratoryproblems,hasbeenidenti-fiedasariskfactorforsevereCOVID-19disease.InformationontheclinicalcourseofSARS-CoV-2infec-tioninchildrenwithcysticfibrosis(CF)islimited,yetvitaltoprovideaccurateadviceforchildrenwithCF,theirfamilies,caregiversandclinicalteams.Methods:CasesofSARS-CoV-2infectioninchildrenwithCFagedlessthan18yearswerecollatedbytheCFRegistryGlobalHarmonizationGroupacross13countriesbetween1Februaryand7August2020.Results:Dataon105childrenwerecollatedandanalysed.Medianageofcaseswastenyears(interquar-tilerange6–15),54%weremaleandmedianpercentagepredictedforcedexpiratoryvolumeinonesecond was94%(interquartilerange79–104).Themajority(71%)ofchildrenweremanagedinthecommunityduringtheirCOVID-19illness.Outof24childrenadmittedtohospital,sixrequiredsupplementaryoxygenandtwonon-invasiveventilation.Aroundhalfwereprescribedantibiotics,fivechildrenreceivedantivi-raltreatments,fourazithromycinandoneadditionalcorticosteroids.ChildrenthatwerehospitalisedhadlowerlungfunctionandreducedbodymassindexZ-scores.Onechilddiedsixweeksaftertestingposi-tiveforSARS-CoV-2followingadeteriorationthatwasnotattributedtoCOVID-19disease. Conclusions:SARS-CoV-2infectioninchildrenwithCFisusuallyassociatedwithamildillnessinthosewhodonothavepre-existingseverelungdisease
COVID-19; Children; Cystic fibrosis
Settore MED/38 - Pediatria Generale e Specialistica
2021
3-dic-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS1569199320309310.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 399.6 kB
Formato Adobe PDF
399.6 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/799967
Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 53
social impact